Your browser doesn't support javascript.
loading
Protective Efficacy and Long-Term Immunogenicity in Cynomolgus Macaques by Ebola Virus Glycoprotein Synthetic DNA Vaccines.
Patel, Ami; Reuschel, Emma L; Kraynyak, Kimberly A; Racine, Trina; Park, Daniel H; Scott, Veronica L; Audet, Jonathan; Amante, Dinah; Wise, Megan C; Keaton, Amelia A; Wong, Gary; Villarreal, Daniel O; Walters, Jewell; Muthumani, Kar; Shedlock, Devon J; de La Vega, Marc-Antoine; Plyler, Ross; Boyer, Jean; Broderick, Kate E; Yan, Jian; Khan, Amir S; Jones, Shane; Bello, Alexander; Soule, Geoff; Tran, Kaylie N; He, Shihua; Tierney, Kevin; Qiu, Xiangguo; Kobinger, Gary P; Sardesai, Niranjan Y; Weiner, David B.
Afiliação
  • Patel A; The Wistar Institute of Anatomy and Biology, Philadelphia, Pennsylvania.
  • Reuschel EL; The Wistar Institute of Anatomy and Biology, Philadelphia, Pennsylvania.
  • Kraynyak KA; Inovio Pharmaceuticals Inc., Plymouth Meeting, Pennsylvania.
  • Racine T; Special Pathogens Program, National Microbiology Laboratory, Public Health Agency of Canada, Winnipeg, Manitoba, Canada.
  • Park DH; Department of Medical Microbiology, University of Manitoba, Winnipeg, Canada.
  • Scott VL; The Wistar Institute of Anatomy and Biology, Philadelphia, Pennsylvania.
  • Audet J; College of Osteopathic Medicine, William Carey University, Hattiesburg, Mississippi.
  • Amante D; Special Pathogens Program, National Microbiology Laboratory, Public Health Agency of Canada, Winnipeg, Manitoba, Canada.
  • Wise MC; Department of Medical Microbiology, University of Manitoba, Winnipeg, Canada.
  • Keaton AA; Inovio Pharmaceuticals Inc., Plymouth Meeting, Pennsylvania.
  • Wong G; Inovio Pharmaceuticals Inc., Plymouth Meeting, Pennsylvania.
  • Villarreal DO; The Wistar Institute of Anatomy and Biology, Philadelphia, Pennsylvania.
  • Walters J; Special Pathogens Program, National Microbiology Laboratory, Public Health Agency of Canada, Winnipeg, Manitoba, Canada.
  • Muthumani K; University of Pennsylvania, Philadelphia.
  • Shedlock DJ; Inovio Pharmaceuticals Inc., Plymouth Meeting, Pennsylvania.
  • de La Vega MA; The Wistar Institute of Anatomy and Biology, Philadelphia, Pennsylvania.
  • Plyler R; University of Pennsylvania, Philadelphia.
  • Boyer J; Special Pathogens Program, National Microbiology Laboratory, Public Health Agency of Canada, Winnipeg, Manitoba, Canada.
  • Broderick KE; University of Pennsylvania, Philadelphia.
  • Yan J; Inovio Pharmaceuticals Inc., Plymouth Meeting, Pennsylvania.
  • Khan AS; Inovio Pharmaceuticals Inc., Plymouth Meeting, Pennsylvania.
  • Jones S; Inovio Pharmaceuticals Inc., Plymouth Meeting, Pennsylvania.
  • Bello A; Inovio Pharmaceuticals Inc., Plymouth Meeting, Pennsylvania.
  • Soule G; Special Pathogens Program, National Microbiology Laboratory, Public Health Agency of Canada, Winnipeg, Manitoba, Canada.
  • Tran KN; Special Pathogens Program, National Microbiology Laboratory, Public Health Agency of Canada, Winnipeg, Manitoba, Canada.
  • He S; Special Pathogens Program, National Microbiology Laboratory, Public Health Agency of Canada, Winnipeg, Manitoba, Canada.
  • Tierney K; Special Pathogens Program, National Microbiology Laboratory, Public Health Agency of Canada, Winnipeg, Manitoba, Canada.
  • Qiu X; Special Pathogens Program, National Microbiology Laboratory, Public Health Agency of Canada, Winnipeg, Manitoba, Canada.
  • Kobinger GP; Special Pathogens Program, National Microbiology Laboratory, Public Health Agency of Canada, Winnipeg, Manitoba, Canada.
  • Sardesai NY; Special Pathogens Program, National Microbiology Laboratory, Public Health Agency of Canada, Winnipeg, Manitoba, Canada.
  • Weiner DB; Department of Medical Microbiology, University of Manitoba, Winnipeg, Canada.
J Infect Dis ; 219(4): 544-555, 2019 01 29.
Article em En | MEDLINE | ID: mdl-30304515

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Doença pelo Vírus Ebola / Vacinas de DNA / Vacinas contra Ebola / Ebolavirus Idioma: En Ano de publicação: 2019 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Doença pelo Vírus Ebola / Vacinas de DNA / Vacinas contra Ebola / Ebolavirus Idioma: En Ano de publicação: 2019 Tipo de documento: Article